chr6-35452597-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021922.3(FANCE):c.52C>T(p.Pro18Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000205 in 1,321,212 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P18L) has been classified as Likely benign.
Frequency
Consequence
NM_021922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FANCE | ENST00000229769.3 | c.52C>T | p.Pro18Ser | missense_variant | 1/10 | 1 | NM_021922.3 | ENSP00000229769.2 | ||
FANCE | ENST00000696264.1 | c.52C>T | p.Pro18Ser | missense_variant | 1/8 | ENSP00000512511.1 | ||||
FANCE | ENST00000648059.1 | n.52C>T | non_coding_transcript_exon_variant | 1/11 | ENSP00000497902.1 | |||||
FANCE | ENST00000696265.1 | n.52C>T | non_coding_transcript_exon_variant | 1/9 | ENSP00000512512.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151802Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000579 AC: 29AN: 50104Hom.: 0 AF XY: 0.000831 AC XY: 25AN XY: 30072
GnomAD4 exome AF: 0.000211 AC: 247AN: 1169300Hom.: 3 Cov.: 30 AF XY: 0.000266 AC XY: 151AN XY: 566960
GnomAD4 genome AF: 0.000158 AC: 24AN: 151912Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74276
ClinVar
Submissions by phenotype
Fanconi anemia complementation group E Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2025 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Fanconi anemia Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Aug 24, 2021 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at